Critical aspects of initiation, promotion, and progression in multistage epidermal carcinogenesis - PubMed (original) (raw)
Review
Critical aspects of initiation, promotion, and progression in multistage epidermal carcinogenesis
H Hennings et al. Proc Soc Exp Biol Med. 1993 Jan.
Abstract
Carcinogenesis in mouse skin can be divided into three distinct stages: initiation, promotion, and progression (malignant conversion). Initiation, induced by a single exposure to a genotoxic carcinogen, can result from a mutation in a single critical gene (e.g., rasHa), apparently in only a few epidermal cells. The change is irreversible. Promotion, resulting in the development of numerous benign tumors (papillomas), is accomplished by the repeated application of a nonmutagenic tumor promoter. The effects of single applications of tumor promoters are reversible since papillomas do not develop after insufficient exposure of initiated skin to promoters or when the interval between individual promoter applications is increased sufficiently. The reversibility of promotion suggests an epigenetic mechanism. Promoter treatment provides an environment that allows the selective clonal expansion of foci of initiated cells. The conversion of squamous papillomas to carcinomas (termed progression or malignant conversion) occurs spontaneously at a low frequency. The rate of progression to malignancy can be significantly increased by treatment of papilloma-bearing mice with certain genotoxic agents. These progressor agents or converting agents are likely to act via a second genetic change in papillomas already bearing the initiating mutation. Progression in the skin is characterized by genetic changes that result in several distinct changes in the levels or activity of structural proteins, growth factors, and proteases. The mechanisms involved in progression are being studied in epidermal cell culture. In order to determine the in vivo phenotype of cultured cells, a grafting system was developed in which the cells were transferred from culture to a prepared skin bed in athymic mice. Introduction of an activated v-fos oncogene into initiated cells bearing an activated rasHa gene produced cells with a carcinoma phenotype, i.e., carcinomas formed when the cells were grafted as part of reconstituted skin. Grafted keratinocytes containing the rasHa gene alone produced papillomas; with v-fos alone, normal skin formed when grafted. The rasHa/fos carcinomas showed changes in differentiation markers characteristic of chemically induced carcinomas. A cell culture assay utilizing cells initiated by the introduction of an activated rasHa oncogene was developed to study progression. After exposure of initiated cells to progressor agents under conditions in which the proliferation of the rasHa-initiated cells was suppressed, proliferating foci developed, with a good correlation of activity in the assay with activity in the progression stage in vivo. The cell culture assay provides a quantitative model to study chemically induced neoplastic progression and may be useful to identify potential progressor agents.
Similar articles
- Development of an in vitro model to study carcinogen-induced neoplastic progression of initiated mouse epidermal cells.
Morgan D, Welty D, Glick A, Greenhalgh D, Hennings H, Yuspa SH. Morgan D, et al. Cancer Res. 1992 Jun 1;52(11):3145-56. Cancer Res. 1992. PMID: 1375535 - Transfection of the EJ rasHa gene into keratinocytes derived from carcinogen-induced mouse papillomas causes malignant progression.
Harper JR, Roop DR, Yuspa SH. Harper JR, et al. Mol Cell Biol. 1986 Sep;6(9):3144-9. doi: 10.1128/mcb.6.9.3144-3149.1986. Mol Cell Biol. 1986. PMID: 2431297 Free PMC article. - Role of oncogenes and tumor suppressor genes in multistage carcinogenesis.
Yuspa SH, Długosz AA, Cheng CK, Denning MF, Tennenbaum T, Glick AB, Weinberg WC. Yuspa SH, et al. J Invest Dermatol. 1994 Nov;103(5 Suppl):90S-95S. doi: 10.1111/1523-1747.ep12399255. J Invest Dermatol. 1994. PMID: 7963691 Review. - Molecular and cellular basis for tumor promotion in mouse skin.
Yuspa SH. Yuspa SH. Princess Takamatsu Symp. 1983;14:315-26. Princess Takamatsu Symp. 1983. PMID: 6394593 Review. - Molecular mechanisms of malignant conversion in skin carcinogenesis.
Yuspa SH, Greenhalgh DA. Yuspa SH, et al. Princess Takamatsu Symp. 1989;20:281-8. Princess Takamatsu Symp. 1989. PMID: 2518687
Cited by
- Targeted disruption of stat3 reveals a major role for follicular stem cells in skin tumor initiation.
Kim DJ, Kataoka K, Rao D, Kiguchi K, Cotsarelis G, Digiovanni J. Kim DJ, et al. Cancer Res. 2009 Oct 1;69(19):7587-94. doi: 10.1158/0008-5472.CAN-09-1180. Epub 2009 Sep 8. Cancer Res. 2009. PMID: 19738054 Free PMC article. - Bacterial infection as a cause of cancer.
Parsonnet J. Parsonnet J. Environ Health Perspect. 1995 Nov;103 Suppl 8(Suppl 8):263-8. doi: 10.1289/ehp.95103s8263. Environ Health Perspect. 1995. PMID: 8741796 Free PMC article. Review. - Modulation of protein kinase signaling cascades by palytoxin.
Wattenberg EV. Wattenberg EV. Toxicon. 2011 Mar 1;57(3):440-8. doi: 10.1016/j.toxicon.2010.11.003. Epub 2010 Nov 9. Toxicon. 2011. PMID: 21070801 Free PMC article. Review. - Disintegrins from snake venoms and their applications in cancer research and therapy.
Arruda Macêdo JK, Fox JW, de Souza Castro M. Arruda Macêdo JK, et al. Curr Protein Pept Sci. 2015;16(6):532-48. doi: 10.2174/1389203716666150515125002. Curr Protein Pept Sci. 2015. PMID: 26031306 Free PMC article. Review. - Molecular targets in urothelial cancer: detection, treatment, and animal models of bladder cancer.
Smolensky D, Rathore K, Cekanova M. Smolensky D, et al. Drug Des Devel Ther. 2016 Oct 5;10:3305-3322. doi: 10.2147/DDDT.S112113. eCollection 2016. Drug Des Devel Ther. 2016. PMID: 27784990 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical